Lundbeck’s Experimental Migraine Drug Shows Promise in Mid-Stage Trial, Offering Hope for Treatment-Resistant Patients
Copenhagen, Denmark — June 4, 2026 Danish pharmaceutical company Lundbeck announced positive mid-stage clinical trial results today for bocunebart,...
French Fries, Not Potatoes: New 40-Year Study Reveals What Really Drives Type 2 Diabetes Risk
The humble potato has long been caught in nutrition’s crosshairs—praised for its potassium, fiber, and B vitamins while simultaneously demonized for...
Behind the Numbers: Why Global Progress on Saving Children’s Lives Has Ground to a Dangerous Crawl
GENEVA — An estimated 4.9 million children worldwide died before reaching their fifth birthday in 2024, according to a sweeping set of United...
Deadly Convergence: How Vaccination Gaps and Malnutrition Fueled Bangladesh’s Devastating Measles Crisis as death toll reaches 604
Dhaka, Bangladesh — A catastrophic convergence of flagging immunization coverage and childhood malnutrition has plunged Bangladesh into its most...
ICMR Launches Landmark Screening Initiative to Tackle Kashmir’s Alarming Stomach Cancer Burden
NEW DELHI — In a major public health intervention, the Indian Council of Medical Research (ICMR) has launched a comprehensive four-year cancer...
